Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-122.8%
operating margin TTM
-90.89%
revenue TTM
7.53 Million
revenue per share TTM
1.93$
valuation ratios | |
|---|---|
| pe ratio | -0.42 |
| peg ratio | -0.01 |
| price to book ratio | 2.21 |
| price to sales ratio | 0.56 |
| enterprise value multiple | 0.22 |
| price fair value | 2.21 |
profitability ratios | |
|---|---|
| gross profit margin | 36.96% |
| operating profit margin | -90.89% |
| pretax profit margin | -122.33% |
| net profit margin | -122.8% |
| return on assets | -39.29% |
| return on equity | -1073.76% |
| return on capital employed | -52.22% |
liquidity ratio | |
|---|---|
| current ratio | 0.30 |
| quick ratio | 0.27 |
| cash ratio | 0.12 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 25.10 |
| operating cycle | 41.37 |
| days of payables outstanding | 238.67 |
| cash conversion cycle | -197.30 |
| receivables turnover | 22.43 |
| payables turnover | 1.53 |
| inventory turnover | 14.54 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.15 |
| debt equity ratio | 1.93 |
| long term debt to capitalization | 0.46 |
| total debt to capitalization | 0.66 |
| interest coverage | -4.83 |
| cash flow to debt ratio | -1.40 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.10 |
| cash per share | 0.26 |
| operating cash flow per share | -1.02 |
| free cash flow operating cash flow ratio | 1.08 |
| cash flow coverage ratios | -1.40 |
| short term coverage ratios | -2.52 |
| capital expenditure coverage ratio | -12.77 |
Frequently Asked Questions
When was the last time INVO Bioscience, Inc. (NASDAQ:INVO) reported earnings?
INVO Bioscience, Inc. (INVO) published its most recent earnings results on 14-08-2024.
What is INVO Bioscience, Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. INVO Bioscience, Inc. (NASDAQ:INVO)'s trailing twelve months ROE is -1073.76%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. INVO Bioscience, Inc. (INVO) currently has a ROA of -39.29%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did INVO's net profit margin stand at?
INVO reported a profit margin of -122.8% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is INVO's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.30 in the most recent quarter. The quick ratio stood at 0.27, with a Debt/Eq ratio of 1.93.